MedTrace Logo

Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer

NCT02664792 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2017-02-23

No results posted yet for this study

Summary

To evaluate the diagnostic accuracy of the 18Fluor-fluorodeoxyglucose (\[18F\]FDG) in the Positron Emission Tomography/Computed Tomography (PET/CT) as compared to mediastinoscopy for staging of non-small cel lung carcinoma.

Conditions

  • Non-small Cell Lung Carcinoma

Interventions

OTHER

Use of [18f]FDG - PET/CT for the diagnosis and staging of non-small cell lung carcinoma

Sponsors & Collaborators

  • Instituto do Cérebro do Rio Grande do Sul - InsCer

    collaborator UNKNOWN

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

    collaborator OTHER_GOV

  • Latin American Cooperative Oncology Group

    lead OTHER

Principal Investigators

  • Gustavo Werutsky, MD · Latin American Cooperative Oncology Group

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-07-31
Completion
2016-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02664792 on ClinicalTrials.gov